InvestorsHub Logo
Followers 46
Posts 1658
Boards Moderated 0
Alias Born 09/01/2013

Re: HopeSkeptic post# 4354

Thursday, 03/28/2019 10:09:31 PM

Thursday, March 28, 2019 10:09:31 PM

Post# of 22012
Updated FACTS -> CVSI DOES NOT have SIMILAR or Better financials to CW : 

1) CVSI did $48m revs in 2018 CS did $69.5m

2)CVSI grew 4% from Q3 2018 to Q4 2018. CW grew 21% from Q3 2018 to Q4 2018 . CVSI also warned Q1 would be slow growth.

3) In earlier presentations, CW forecast for 2019 is $120-$170m revs , CVSI does not even give a forecast but CW forecast looks like they could start to seriously lap them as CVSI had little growth from Q3 2018 to Q4 2018 and warned Q1 2019 would be the same. 

4) CVSI GM% was 70% for 2018 CW GM% was 75% for 2018. 

4) CVSI Adjusted EBITDA % was 29% for 2018 CW Adjusted EBITDA % was 30% for 2018.

5) CW has $73m cash and CVSI has $13m cash and is developing a drug (which requires a lot of $ for trials) besides their CBD business
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CWBHF News